Burning Rock Biotech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-589.99	-653.69	-971.23	-796.7	-471.92	-334.17	Upgrade
Depreciation & Amortization	-	133.4	124.1	47.77	33.31	31.36	Upgrade
Share-Based Compensation	-	260.72	326.78	282.43	173.22	22.79	Upgrade
Other Operating Activities	407.14	3.79	63.55	-11.39	127.16	-113.04	Upgrade
Operating Cash Flow	-182.85	-255.78	-456.81	-477.89	-73.54	-228.04	Upgrade
Capital Expenditures	-8.02	-8.02	-67.88	-210.35	-74.93	-45.24	Upgrade
Change in Investments	-	0	60.6	294.58	-30.42	-301.02	Upgrade
Other Investing Activities	0.39	-1.28	-0.19	-2.53	-3.97	-0.4	Upgrade
Investing Cash Flow	-7.63	-9.3	-7.46	81.7	-109.31	-346.66	Upgrade
Share Issuance / Repurchase	-	-48.83	-83.87	-8.09	1,920	-3.64	Upgrade
Debt Issued / Paid	-	0	-2.37	-44.81	-20.59	-81.6	Upgrade
Other Financing Activities	-48.8	-	-	-	266.47	656.97	Upgrade
Financing Cash Flow	-48.8	-48.83	-86.24	-52.9	2,166	571.74	Upgrade
Exchange Rate Effect	8.81	3.86	36.67	-37.01	-155.9	5.88	Upgrade
Net Cash Flow	-230.47	-310.05	-513.84	-486.09	1,827	2.91	Upgrade
Free Cash Flow	-190.87	-263.8	-524.68	-688.24	-148.47	-273.28	Upgrade
Free Cash Flow Margin	-36.67%	-49.09%	-93.15%	-135.52%	-34.54%	-71.60%	Upgrade
Free Cash Flow Per Share	-18.61	-25.76	-50.49	-66.05	-21.63	-111.83	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).